Imagine an automated insulin delivery system that is able to connect with other devices seamlessly. A state-of-the-art, tubeless technology that provides continuous insulin therapy, operates on its own platform and publishes its own communication protocol.
Thanks to a new partnership between JDRF and medical technology company, SFC Fluidics, Inc., this functional insulin patch pump may soon revolutionize the lives of people living with type 1 diabetes (T1D) and become the highly sought technology among patients with the disease.
A two-year funding commitment from JDRF will enable SFC Fluidics to foster the development and delivery of the interoperable insulin pump. The new technology enables flawless, secure connectivity with other devices (e.g., Bluetooth) such as continuous glucose monitors and other third-party automated insulin delivery technologies (e.g., solutions by the do-it-yourself community).
For more than a decade, JDRF has played a leadership role in accelerating the expansion and commercialization of artificial pancreas (AP) systems that program insulin delivery. In 2017, JDRF launched its Open-Protocol Automated Insulin Delivery (AID) Systems Initiative and worked with key stakeholders to identify the regulatory and liability implications of an open-protocol AID ecosystem.
This new solution is expected to not only provide a greater range of future treatment options for people living with T1D, but to also increase the adoption of these cutting-edge, life-enhancing technologies.
For more informative articles on health and type 1 diabetes, visit our JDRF Blog.
Researchers at Oxford University (UK) are offering powdered insulin to babies at high risk of developing type 1 diabetes (T1D) with the hope of training their immune systems to tolerate the insulin they produce, thereby offering life-long protection against the disease.
The goal of POInT (Primary Oral Insulin Trial) is to introduce immune tolerance to insulin, as T1D results from the body’s defense system attacking and destroying insulin-producing cells in the pancreas.
Researchers will perform a prick blood test to screen the eligibility of 300,000 babies who have been identified with high chances of getting T1D through genetic markers.
From the age of about six months until they are three years old, children in the trial will then be given a small dose of insulin powder daily together with a meal. Half of the study participants will be offered the real insulin while the other half will receive a placebo (capsule containing no drug). In order to assess the efficacy of the treatment, neither the children nor the investigators will know which capsules contain insulin and which contain a placebo. The children’s health will be monitored via visits from the research team.
Previous studies have shown that oral administration of insulin is safe and does not affect sugar levels. Researchers are hopeful this pioneering therapy will become a preventive treatment in the future for all babies with an elevated genetic predisposition for T1D.
POInT is being funded by the National Institute for Health Research, JDRF, Diabetes UK and the Wellcome Trust, as well as the Leona M. and Harry B. Helmsley Charitable Trust.
For more informative articles on health and type 1 diabetes, visit our JDRF Blog.
JDRF has joined forces with Danish biotech company, Gubra, to develop a glucose-responsive insulin (GRI) as a treatment for people with insulin-dependent diabetes. The Gubra approach is based on a long-standing goal of researchers in the field to create a form of insulin that could linger in the bloodstream and become active only when needed.
People with type 1 diabetes (T1D) must check their blood glucose several times a day and rely on insulin injections to keep their blood sugar levels within a healthy range. Gubra’s GRI product is designed to work when blood glucose levels rise too high and to be inactive when they are in or below the standard value. The unique approach combines properties of bolus insulin (insulin that controls glucose levels at meal times) with those of a long-acting basal insulin (insulin that controls blood glucose levels during periods of fasting) to provide not only improved overall blood glucose control, but also a safer and simpler drug for people with T1D. This GRI can therefore respond to fluctuations in blood glucose levels after eating more rapidly and naturally than conventional fast-acting insulins without the risk of hypoglycemia (low blood sugar).
“JDRF is excited to partner with Gubra on developing a novel glucose-responsive insulin, which has the potential to disrupt insulin-based treatments and reduce late stage T1D complications,” says JDRF scientist,
Dr. Jonathan Rosen.
JDRF’s funding commitment will help advance Gubra’s new insulin product towards clinical and pharmaceutical development.
For more informative articles on health and type 1 diabetes news visit the Research News section on our website.
Bringing together diabetes researchers and healthcare professionals from across the globe, the Scientific Sessions is the world’s largest meeting focused on diabetes. The five-day conference is a major event in the type 1 diabetes (T1D) and broader diabetes community that fosters the exchange of ideas with experts in the field, while showcasing ground-breaking developments in areas such as glucose control, beta cell regeneration and artificial pancreas, to name a few.
“At JDRF we are committed to funding innovative therapies to keep people with T1D healthier until a cure is discovered,” says Dave Prowten, president and CEO of JDRF Canada. “Over the past year, there has been progress that is changing the face of T1D and offering hope to everyone living with the disease.”
Among the scheduled presentations at the conference, more than 60 had a JDRF connection. This year also marked the first time that JDRF conducted onsite video interviews with 15 of its researchers to report on their studies or sessions.
Keynote sessions centered on promising T1D research studies that are paving the way to novel treatments. Here are our top three highlights:
Lesson Learned from the Environmental Determinants of Diabetes in the Young (TEDDY) Study—Insights into Early Autoimmune T1D
Research Category: PREVENTION
Funded by JDRF, the National Institutes of Health, the Special Diabetes Program and other organizations, the TEDDY consortium was created to advance our understanding of how environment alters immunity, bringing us closer to prevention of T1D. TEDDY is a project that is tracking children at risk of T1D. Researchers are examining diet, illnesses, allergies and a host of other life experiences in order to determine environmental susceptibility to the disease. At ADA, it was found that children who develop autoimmunity early tend to develop insulin autoantibodies (i.e., antibodies produced by the immune system that are directed against one or more of the individual’s own proteins) first and progress faster to T1D, while those who develop autoimmunity later in childhood tend to develop different autoantibodies and progress more slowly.
Should All Pregnant Women with T1D Use Continuous Glucose Monitors (CGMs)?
Research Category: GLUCOSE CONTROL
JDRF-funded Dr. Denice Feig, the CONCEPTT co-principal investigator, presented her ‘pro’ argument as part of a professional group interest session. Continuous glucose monitoring systems have the potential to revolutionize diabetes management among pregnant and breastfeeding women with T1D because they allow them to take immediate action in response to high or low blood sugars, and avoid other serious health-related issues.
Medalist Studies: International Summit on the Study of T1D of Very Long Duration
Research Category: COMPLICATIONS
Joslin Diabetes Center’s 50-Year Medal Program recognizes individuals who have lived with type 1 diabetes for 50 or more years, and researchers are studying this group to determine factors that may allow them to be resistant to the complications associated with the condition. JDRF has funded nearly $5 million towards the Joslin Medalist Study since 2005, including a Canadian group in 2013.
One of the goals of the Joslin Medalist Summit was to bring together all of the various groups from Australia, United Kingdom, Denmark, Finland and the United States that are working on studying long-duration T1D to see if they could learn from each other, share protocols, harmonize approaches and maximize the possibility of identifying protective factors that can prevent complications, such as eye disease or kidney disease. This was the first-ever summit of all these groups coming together and marks the beginning of continued collaboration to further recognize aspects of long-duration T1D and protective factors.
Watch JDRF’s associate director of research, Dr. Marlon Pragnell, give a recap of the Joslin Medalist meeting and what it could mean to those living with T1D.
Other key JDRF-funded projects addressed at the ADA Sessions included:
Dr. Alessandro Doria and his team at the Joslin Diabetes Center are investigating a medication called allopurinol as a potential treatment to prevent early kidney function loss in diabetes. This research has the potential to delay the onset of dialysis or end-stage kidney disease by as many as 10 to 15 years, and perhaps even prevent both.
Dr. Paresh Dandona and his colleagues at the State University of New York at Buffalo are examining the use of a medication called liraglutide to control glycemic fluctuations in people with T1D. The availability of an additional, effective drug to regulate blood glucose levels could prevent complications and greatly improve their quality of life.Dr. Paresh Dandona discusses a JDRF supported study that saw that use of the medication liraglutide helped to control glycemic oscillations in people with type 1 diabetes (T1D) and significantly lowered HBA1C levels.
Click here for more information on JDRF-funded research projects featured at the ADA’s Scientific Sessions.
For highlights, conference news and video clips from the ADA’s 78th Scientific Sessions, click here.
Visit our JDRF Blog for more informative articles on type 1 diabetes and health.
Long weekends, warm nights, and outdoor get-togethers mean that BBQ season is back! There’s no shortage of things to do in the summer, but when you have type 1 diabetes (T1D) activities such as travelling or indulging in some of your favourite barbecued foods require a bit more planning. While this can seem like a daunting task, having a strategy in place will allow you to feel more confident in your ability to manage changes in your blood glucose levels.
Whether you’ve been invited to a BBQ or you’re intending to host one soon, we’ve got you covered. Here is our Guide to Navigating BBQ season:
BYOD or Bring Your Own Dish
When you’re not at home, it’s more difficult to control your food options, which is why carrying your own dish is always a great idea. Most hosts will be thrilled to see that you’ve brought something, and you can familiarize yourself with its nutritional content ahead of time. Food items supplied by other guests, whether they’re homemade or store-bought, can have hidden sugars and fats, which can lead to blood sugar surprises later.
Circulate, circulate, circulate!
Walk by the buffet a couple of times and decide how many carbs you will be consuming that day. If you find it difficult to keep track download an app on your smartphone that counts carbs, displays glycemic index (GI), or reveals fat content. There is no shortage of apps that show the nutritional information of processed foods, produce and homemade foods, too.
Stay hydrated
On hot days, you run the risk of dehydration, which can spike your blood sugar levels. At a BBQ, you’re more likely to eat salty foods and protein, which can increase the unwanted effects of heat. If you drink an alcoholic beverage it can further increase your risk of dehydration, so be sure you’re making informed decisions before you sip. Drinking water doesn’t have to be boring – dress up your water with lemon, cucumber, or try sparkling water!
Keep your meds cool
You’re not the only one that feels the heat. Insulin should be kept out of the sun and at room temperature, or stored in a fridge. To prevent your insulin from going bad while outdoors bring along a cool pack. Insulin needs to be cool – not frozen –as freezing kills it.
Get moving
Moving around in any form helps to counteract high blood sugar. You’re at a BBQ – dance to a perfectly curated playlist, walk around to mingle, or play lawn games! These are just a few great ways to get active and offset highs.
Have fun!
At times, it can feel like you’re constantly thinking about managing type 1 and forgetting to enjoy yourself. Keep these tips in mind to help you enjoy the great food and company at your next barbecue!
Happy BBQing!
Visit our JDRF Blog for more informative articles on type 1 diabetes and health.
What’s the best way to engage employees, increase productivity, induce positive culture and cultivate collaboration? If you’re a Canadian business, the answer is the distinguishing factor between a thriving workforce and a revolving door.
In the shifting sands of evolving workplaces, businesses are facing unique challenges to build structures that embrace employees’ individualities and needs. Philanthropic efforts are being implemented by successful businesses to engage employees, build brand integrity, and create positive change for people in their communities, but how else can it help?
The JDRF Revolution Ride to Defeat Diabetes presented by Sun Life Financial has an answer.
Actually, they have 5.
JDRF Revolution Ride to Defeat Diabetes Presented by Sun Life Financial
The JDRF Revolution Ride to Defeat Diabetes is a high-energy stationary cycling event taking place in cities across Canada. This event challenges Canadians to go further to defeat diabetes. Whether it’s a 10-minute ride or a 60-minute endurance challenge, participants will be put to the test to help find a cure for type 1 diabetes (T1D).
1. Addressing the increasingly dynamic workplace
A study by Regent Canada indicates that 47% of Canadian employees work from outside their employer’s main offices for half the week or more. Employees working remotely face a greater challenge absorbing a company’s values for one simple reason: less time in the office equals less time to be engaged.
The Revolution Ride creates the flexibility needed to be inclusive of all employees. With the option of a virtual ride (or vRide), anyone can participate remotely at anytime from anywhere in the world, whether it’s a spin studio down the street or a hotel gym; this means employees in Vancouver can compete with their Halifax branch as easily as if they were riding side by side.
2. Identifying qualities of effective team-building
Successful team building eliminates barriers, embraces equality, and promotes positive interactions that generate valuable opportunities for employees to forge real relationships tempered by comradery and trust.
The Revolution Ride integrates all participants, from executives to office clerks, into an atmosphere that brings everyone onto the same page and working towards the same goal. It’s the optimal environment to enrich a great team dynamic and help businesses build new foundations on which their team can grow.
3. Eliminating self-interest to conduce effective networking
The purpose of networking is jeopardized when self-interest overrides the notion of building real relationships. The Revolution Ride restores effective networking by creating an organic opportunity to connect and communicate with likeminded individuals in a collaborative setting. While 1 team member rides, the other 4 will be cheering them on alongside 40-plus teams doing the same, creating a social environment that induces high-spirits and friendly competition.
The customizability of JDRF’s Ride format makes it easy for everyone to participate. For example, a small law firm putting together a team of 5 employees to participate in the Ride10 would mean closing up shop for the day. So instead, invite 4 clients and turn team-building into networking. Or, let’s take someone who works for an IT department within a bank. Bankers might not be this person’s ideal candidates to network with, so the IT employee can switch time slots and ride in the tech sector.
4. Using social corporate responsibility to align employee and company values
Employees need a higher sense of purpose through their work, and smart businesses ensure they find it. Employees with a sense of purpose stay longer and are instrumental in attracting and retaining prospective employees. According to Forbes, 50% of millennials would take a pay cut to work somewhere where their company’s values align with theirs. Businesses can create these alignments by tackling corporate social responsibilities.
The Revolution Ride is an opportunity to stand proudly on the upside of change. Businesses that identify with philanthropic efforts not only define their brand as compassionate, they strengthen their relationships with their employees and the public. The Revolution Ride taps into an employee’s sense of purpose and puts them in the driver’s seat to generate positive change.
5. Addressing employee health as a staple of success
Maintaining the quality of employee health is a priority for all recruitment strategists because it directly impacts performance and company culture. Employees want to work where they feel valued, so businesses being considerate of their employees’ health is a critical step in retention. The Mental Health Commission of Canada states that absenteeism related to mental health costs Canada 6-billion dollars per-year. The takeaway is that businesses need to create supportive environments that their employees feel good about coming to work in.
The Revolution Ride thrives because it’s inclusive and provides a physical, fun outlet for riders that is more social than athletic. The supportive and encouraging nature of participants year after year is what continuously attracts diverse groups of people to come together to be physically active while challenging themselves and each other. Businesses can take advantage of this positive atmosphere to instill health as a staple of their company culture, promoting the importance of physical and mental wellness in an environment that is free of judgment and full of positivity.
About Type 1 Diabetes:
Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin. Insulin is a hormone that enables people to get energy from food. T1D isn’t caused by our lifestyle choices. There is nothing anyone can do to prevent it, and at present, there is no cure. It can affect both children and adults and lasts a lifetime. For these individuals, symptoms can only be addressed with the use of insulin.
Over 300,000 Canadians live with type 1 diabetes, and the national average incidence rate has been growing at an estimated 5.1% per year. Approximately 250 individuals will be diagnosed with type 1 diabetes this week – 50 per day in Canada. JDRF (Juvenile Diabetes Research Foundation) tackles the challenges of type 1 diabetes by hosting events to raise funds for vital research into treatments and finding a cure. The support of you and your colleagues will help us turn type 1 into type none.
By joining the JDRF Revolution Ride to Defeat Diabetes, your team will be raising awareness and funds to search for a cure. Register your team today.
By Patrick Tohill, Government Relations Director at JDRF Canada
We’ve got some exciting updates with respect to our campaign around the Disability Tax Credit and the Registered Disability Savings Plan. A senate committee tasked with studying these issues is urging the government to take a more compassionate approach in terms of the way these programs work for people living with disabilities in Canada.
JDRF has welcomed the report and is broadly supportive of the recommendations. Parents of type 1 children as well as adults living with the disease who’ve invested in RDSPs will be pleased with the senators’ recommendation that the period of time between when contributions to RDSPs are made and when they can be withdrawn be reduced from 10 years to five.
Also included within the Senate’s recommendations are two or three ideas that stem from JDRF’s testimony back in February. For example, the report recommends that investments and government contributions to RDSPs not be clawed back if the person was eligible for DTC when the investments were made, as well as that all eligibility criteria for the DTC be reviewed. The report specifically mentions the 14 hour per week rule which JDRF has recommended be reduced to 10 hours, though we’d be happy to see it nixed completely.
One particular amendment we’d like to see in terms of eligibility criteria concerns the exclusion of carbohydrate calculation, which makes absolutely no sense. As anyone with type 1 will tell you, you simply cannot calculate insulin dosage, something that’s included as an eligible activity in the 14 hours, without first calculating the number of carbohydrates you’re consuming.
Unfortunately, the Canada Revenue Agency wrongly considers carbohydrate calculation to fall under the category of a dietary restriction and has deemed it to be excluded under the Act. As a result, an application that mentions 280 minutes a week spent determining insulin dosage will be approved and an application mentioning 280 minutes a week calculating carbs will be denied.
JDRF has joined with Diabetes Canada in preparing a joint submission on carb calculation which we’ve submitted to the Disability Advisory Committee, the CRA and the Finance department.
Several of our recommendations around the DTC have also made their way into a Private Member’s Bill, Bill C-399, introduced by Tom Kmiec, MP for Calgary—Shepard in March. The Fairness for Canadians with Disabilities Act would “increase accessibility for disability tax credit for Canadians living with diabetes as well as those with rare disorders”.
by Patrick Tohill, Government Relations Director at JDRF
It’s that time of the year again! We’re opening submissions for Kids for a Cure 2018, an exciting advocacy initiative in which JDRF gets youth from across Canada together to impact the future of diabetes research.
We are seeking 24 youth delegates to represent Canadians with type 1 diabetes on Parliament Hill this fall. Delegates will help Canada’s decision-makers better understand the challenges of living with type 1 diabetes and the importance of funding research to help those with the disease live easier, healthier, safer lives until a cure can be found.
Our ideal delegate is articulate, outgoing and passionate about creating a world without T1D. Applicants should also fall between the ages of 4-18 at the time of the event.
So how does it work?
JDRF will cover the costs of airfare, accommodation, meals and ground transportation for those applicants selected as Kids for a Cure 2018 delegates and one parent or guardian.
Those selected as Kids for a Cure youth delegates are expected to complete a scrapbook designed to help them tell their T1D story and participate in mandatory training sessions (two online and one in person on the day of arrival in Ottawa).
Here are the details:
Event Date: October 28-30th, 2018
Location: Parliament Hill, Ottawa
Eligibility: Aged 4 to 18 on October 30th.
Application Deadline: Tues., July 31st, 2018 by MIDNIGHT EDT.
Application Process:
Complete the application.
Record and upload a one minute video telling us why we need you on Team JDRF.
Is this you? We’d love to hear from you? Do you know of anyone who would be a great fit? Share this article with them!
Please note that we expect to receive four applications for every one delegate chosen. While we appreciate everyone’s effort in completing the application, we cannot guarantee participation. All applicants, successful or otherwise, will be notified in late August.
And remember, you can support JDRF Advocacy even if you’re not selected. Simply tick the box saying you’d like to join our Advocates list when completing your application.
We welcome any comments, questions or concerns you may have about this event, so please reach out at ptohill@jdrf.ca.
Maybe you’ve never heard of the term ‘diabulimia’ before, but this eating disorder affecting people living with type 1 diabetes is more common than you might think.
It’s important to know some eating disorders are unique in populations with type 1 diabetes (T1D). But what are the warning signs of the type 1 eating disorder known as ‘diabulimia’? And what are the best forms of treatment? Here’s everything you need to know.
What is diabulimia?
Eating disorders are relatively common in people with T1D. In fact, nearly 1 in 5 children with T1D, and 1 in 4 females, show signs of disturbed eating behaviour.
Diabulimia is an eating disorder that primarily affects young women with T1D. According to Dr. Michael Vallis at the Behavior Change Institute, Nova Scotia Health Authority and Dalhousie University in Halifax, it is characterized by deliberately withholding, or restricting, insulin in order to lose weight, explains
Hemoglobin A1C level of 9.0 or higher on a continuous basis.
Unexplained weight loss.
Persistent thirst/frequent urination.
Preoccupation with body image.
Blood sugar records that do not match Hemoglobin A1C results.
Depression, mood swings and/or fatigue.
Secrecy about blood sugars, shots and or eating.
Repeated bladder and yeast infections.
Low sodium/potassium.
Increased appetite especially in sugary foods.
Cancelled doctors’ appointments.
A lot of these symptoms are the same ones found in early diabetes diagnosis. Some health professionals say it’s as if they were essentially turning back the clock in disease state.
Why is it so dangerous?
Even though restricting insulin does cause weight loss, it also causes blood sugar levels to skyrocket. Over time, this takes a toll on health that can have life-threatening consequences.
Diabulimia can accelerate T1D-related complications in young people, including blindness, kidney failure and limb amputation – conditions that are typically seen in much older patients.
One of the most serious complications is diabetic ketoacidosis (DKA), when a lack of insulin causes the body to burn fat in order to fuel itself, creating toxicity in the body, and potentially resulting in coma or even death.
Why is recovery harder than other conventional eating disorders?
Conventional eating disorder treatment programs, including intensive inpatient programs, often don’t lead to lasting recovery, as they are not geared towards the unique needs of diabulimia patients, so treatment failure rates are high.
How do you effectively treat diabulimia?
Diabulimia, like most eating disorders, begins with low self-esteem. There is a concern about weight, body image and an aim for perfectionism. There’s also a heightened risk of depression in eating disorders for people living with type 1.
Working with a psychiatrist is highly recommended in order to assess the best combination of strategies from various treatment programs.
Recovery is about developing an improved sense of self. To some, this might be practicing yoga and mindfulness; to others it might be exploring different forms of artistic expression. The focus should be on working with professionals that help you assess how to better manage your diabetes and how to build back your sense of worth by reconnecting with what interests and challenges you.
How can I get help?
If you suspect you or someone you know is suffering from diabulimia, you should contact your diabetes healthcare team and/or family physician to discuss referral options and receive support.
Many people still don’t know about diabulimia, that’s why raising awareness about it is so important to prevention and better management. In the future, we hope to see more targeted treatment programs focusing on optimal diabetes management and treating the underlying eating disorder.
Great news for Ontario youth! Insulin, diabetes test strips and other prescriptions are now free for Ontarians who are 24 and under.
While we welcome this new measure, we hope it represents only the first step in achieving the goal of universal pharmacare in all provinces.
Many members of the T1D community have reached out to JDRF with questions about how exactly OHIP+ works. So here’s everything you need to know about OHIP+ and what it means for Canadians with a type 1 diabetes connection.
Who and what’s covered?
OHIP+ covers more than 4,400 drug products for anyone age 24 years or under automatically with an Ontario health card number. This includes insulin and diabetic testing strips for measuring blood sugar.
This table shows the type of treatment and number of test strips covered.
Diabetes Treatment
Maximum number of strips (per year) covered
Patients Managing diabetes with insulin
3,000
Patients managing diabetes insulin medication with higher risk of causing hypoglycemia (low blood sugar)
400
Patients managing diabetes using medication with lower risk of causing hypoglycemia (low blood sugar)
200
Patients managing diabetes through diet/lifestyle therapy only (no insulin or medications used)
200
Source: Ontario Ministry of Health
If you want more than the maximum quantity, you have to pay for it yourself. Syringes and other diabetic supplies, such as lancets, glucometers, eyeglasses, dentures, hearing aids or compression stockings are not covered by OHIP+.
What if I’m a student out of province?
If you’re going to university or college in another province, you’re still covered as long as you have a valid prescription and get your medications from a pharmacy in Ontario. You may be able to get a larger “travel supply” before leaving Ontario.
What other choices do I have?
Other programs help people pay for diabetic supplies in Ontario, such as needles and syringes. Find out if you qualify for other coverage through:
I’m not from Ontario. How does it work in my province?
Each provincial and territorial government offers a drug benefit plan for eligible groups. Some are income-based universal programs. Most have specific programs for population groups that may require more enhanced coverage for high drug costs. For more info, click on your province:
According to the Ontario Ministry of Health, young people aged 19-24 are less likely to have access to prescription drug coverage or the financial means to pay out-of-pocket due to higher unemployment and lower incomes.
Seniors receive coverage for the same prescriptions through the Ontario Drug Benefit.
For middle-aged adults, the Trillium Drug Program is available for people who spend 3 to 4% or more of their after-tax household income on drug costs. It covers the same prescriptions as OHIP+ and doesn’t have an age restriction.
What’s the big deal?
OHIP+ is a great step in the right direction towards universal drug coverage. Ontario is the first province to provide prescription medication coverage at no cost for children and youth age 24 years and under, helping more people afford the medications that they need to stay healthy.
But let’s face it: Diabetes is a very costly disease. We hope that in time, insulin, diabetes supplies, devices and all needed drugs are 100% covered for all ages from coast to coast to coast.
As community member Daneille Owen-Bilida put it: “This is a start, but much more needs to be done.”
P.S: Help us put pressure on decision makers and advocate for better benefits for the T1D community by becoming a JDRF advocate. Join us and make a strong impact with your personal story.
Imagine an automated insulin delivery system that is able to connect with other devices seamlessly. A state-of-the-art, tubeless technology that provides continuous insulin therapy, operates on its own platform and publishes its own communication protocol.
Researchers at Oxford University (UK) are offering powdered insulin to babies at high risk of developing type 1 diabetes (T1D) with the hope of training their immune systems to tolerate the insulin they produce, thereby offering life-long protection against the disease..jpg)
JDRF has joined forces with Danish biotech company, 
Long weekends, warm nights, and outdoor get-togethers mean that BBQ season is back! There’s no shortage of things to do in the summer, but when you have type 1 diabetes (T1D) activities such as travelling or indulging in some of your favourite barbecued foods require a bit more planning. While this can seem like a daunting task, having a strategy in place will allow you to feel more confident in your ability to manage changes in your blood glucose levels..png)
The customizability of JDRF’s Ride format makes it easy for everyone to participate. For example, a small law firm putting together a team of 5 employees to participate in the 
The